{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:46:14Z","timestamp":1787168774046,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.clim.2018.12.013","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T14:01:09Z","timestamp":1544450469000},"page":"52-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Autoimmune interstitial lung disease in Latin-America"],"prefix":"10.1016","volume":"199","author":[{"given":"F.","family":"Vivero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Campins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Malfante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Babini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Enghelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clim.2018.12.013_bb0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.clim.2018.12.013_bb0010","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1164\/rccm.200301-137OC","article-title":"Clinical diagnosis of hypersensitivity pneumonitis","volume":"168","author":"Lacasse","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.clim.2018.12.013_bb0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000079633","article-title":"Interstitial lung disease induced by drugs and radiation","volume":"71","author":"Camus","year":"2004","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.clim.2018.12.013_bb0020","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1378\/chest.12-0741","article-title":"Diagnosis and treatment of connective tissue disease-associated interstitial lung disease","volume":"143","author":"Vij","year":"2013","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.clim.2018.12.013_bb0025","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.clim.2018.12.013_bb0030","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.200611-1685OC","article-title":"Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project","volume":"177","author":"Travis","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.clim.2018.12.013_bb0035","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.clim.2018.12.013_bb0040","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.rmed.2008.04.023","article-title":"ANCA-associated lung fibrosis: analysis of 17 patients","volume":"102","author":"Foulon","year":"2008","journal-title":"Respir. Med."},{"key":"10.1016\/j.clim.2018.12.013_bb0045","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.clim.2018.12.013_bb0050","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir. Med."},{"issue":"10","key":"10.1016\/j.clim.2018.12.013_bb0055","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/art.30467","article-title":"Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group","volume":"63","author":"Khanna","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.12.013_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-0034-1371531","article-title":"Immunosuppression for connective tissue disease \u2013 related pulmonary disease","volume":"35","author":"Maher","year":"2014","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.clim.2018.12.013_bb0065","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s10067-011-1840-0","article-title":"Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases","volume":"30","author":"Yu","year":"2011","journal-title":"Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.clim.2018.12.013_bb0070","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer","year":"2013","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.clim.2018.12.013_bb0075","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.autrev.2017.12.010","article-title":"Efficacy and safety of rituximab in systemic sclerosis: french retrospective study and literature review","volume":"17","author":"Thiebaut","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2018.12.013_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12890-017-0453-z","article-title":"Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features","volume":"17","author":"Ito","year":"2017","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.clim.2018.12.013_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2017.03.004","article-title":"Idiopathic interstitial pneumonia associated with autoantibodies: a large case series followed over one year","author":"Collins","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.clim.2018.12.013_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/759760","article-title":"The multifaceted aspects of interstitial lung disease in rheumatoid arthritis","author":"Cavagna","year":"2013","journal-title":"BioMed. Res. Int."},{"issue":"2","key":"10.1016\/j.clim.2018.12.013_bb0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.autrev.2017.09.013","article-title":"Imaging aspects of interstitial lung disease in patients with rheumatoid arthritis: literature review","volume":"17","author":"Balbir-Gurman","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.clim.2018.12.013_bb0100","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.autrev.2016.07.025","article-title":"Pulmonary involvement in systemic sclerosis","volume":"15","author":"Morales-C\u00e1rdenas","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.clim.2018.12.013_bb0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","article-title":"Marie I interstitial lung disease in primary Sj\u00f6gren's syndrome","volume":"16","author":"Roca","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.clim.2018.12.013_bb0110","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.22532","article-title":"Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors","volume":"57","author":"McNearney","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.12.013_bb0115","article-title":"Sj\u00f6gren's syndrome-associated interstitial lung disease: a multicenter study","author":"Reina","year":"2015","journal-title":"Reumatol. Clin."},{"issue":"7","key":"10.1016\/j.clim.2018.12.013_bb0120","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.autrev.2017.05.008","article-title":"Interstital lung disease in ANCA vasculitis","volume":"16","author":"Alba","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2018.12.013_bb0125","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/ard.2008.096131","article-title":"Pulmonary fibrosis associated with ANCA positive vasculitides: retrospective study of 12 cases and review of the literature","volume":"68","author":"Hervier","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2018.12.013_bb0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-1843.2004.00581.x","article-title":"Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides","volume":"9","author":"Homma","year":"2004","journal-title":"Respirology"},{"key":"10.1016\/j.clim.2018.12.013_bb0135","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.rmed.2008.04.023","article-title":"ANCA-associated lung fibrosis: analysis of 17 patients","volume":"102","author":"Foulon","year":"2008","journal-title":"Respir. Med."},{"issue":"11","key":"10.1016\/j.clim.2018.12.013_bb0140","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.clim.2018.12.013_bb0145","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.clim.2018.12.013_bb0150","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2169\/internalmedicine.49.2889","article-title":"Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies","volume":"49","author":"Koreeda","year":"2010","journal-title":"Intern. Med."},{"issue":"9","key":"10.1016\/j.clim.2018.12.013_bb0155","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.12.013_bb0160","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/01.rct.0000135280.79012.c7","article-title":"Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease. CT findings in 51 patients","volume":"28","author":"Ando","year":"2004","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"6","key":"10.1016\/j.clim.2018.12.013_bb0165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/oxfordjournals.aje.a112054","article-title":"Community surveillance for coronary heart disease: the Framingham Cardiovascular Disease Survey. Methods and preliminary results","volume":"100","author":"Margolis","year":"1974","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.clim.2018.12.013_bb0170","author":"Global Initiative for Asthma"},{"key":"10.1016\/j.clim.2018.12.013_bb0175","author":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease"},{"issue":"5","key":"10.1016\/j.clim.2018.12.013_bb0180","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/03009740600844381","article-title":"Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography","volume":"35","author":"Afeltra","year":"2006","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.clim.2018.12.013_bb0185","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.rmed.2016.09.002","article-title":"Clinical features and natural history of interstitial pneumonia with autoimmune features: a single center experience","volume":"119","author":"Chartrand","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.clim.2018.12.013_bb0190","article-title":"Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients","author":"Ahmad","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.clim.2018.12.013_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2214\/AJR.16.17121","article-title":"CT findings, radiologic-pathologic correlation, and imaging predictors of survival for patients with interstitial pneumonia with autoimmune features","volume":"208","author":"Chung","year":"2017","journal-title":"AJR"},{"key":"10.1016\/j.clim.2018.12.013_bb0200","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01565-2015","article-title":"Characterisation of patients with interstitial pneumonia with autoimmune features","author":"Oldham","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clim.2018.12.013_bb0205","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1164\/rccm.200402-147OC","article-title":"Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?","volume":"170","author":"Flaherty","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.clim.2018.12.013_bb0210","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(16)30033-9","article-title":"Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study","volume":"4","author":"Walsh","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.clim.2018.12.013_bb0215","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0034-1371530","article-title":"Cross-disciplinary collaboration in connective tissue disease-related lung disease","volume":"35","author":"Fischer","year":"2014","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.clim.2018.12.013_bb0220","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/rheumatology\/keq233","article-title":"The impact of rheumatological evaluation in the management of patients with interstitial lung disease","volume":"50","author":"Castelino","year":"2011","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.clim.2018.12.013_bb0225","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.200702-220OC","article-title":"Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?","volume":"176","author":"Kinder","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.clim.2018.12.013_bb0230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1378\/chest.10-0194","article-title":"Connective tissue disease-associated interstitial lung disease: a call for clarification","volume":"138","author":"Fisher","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.clim.2018.12.013_bb0235","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1378\/chest.10-2662","article-title":"Autoimmune-featured interstitial lung disease: a distinct entity","volume":"140","author":"Vij","year":"2011","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.clim.2018.12.013_bb0240","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1183\/09031936.00174910","article-title":"Significance of connective tissue disease features in idiopathic interstitial pneumonia","volume":"39","author":"Corte","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clim.2018.12.013_bb0245","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1183\/09031936.00101506","article-title":"Interstitial lung disease: are we missing formes frustes of connective tissue disease?","volume":"28","author":"Cottin","year":"2006","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.clim.2018.12.013_bb0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1183\/13993003.02084-2015","volume":"47","author":"Collins","year":"2016","journal-title":"ERJ"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161830723X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161830723X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T21:01:51Z","timestamp":1552597311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166161830723X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":50,"alternative-id":["S152166161830723X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2018.12.013","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune interstitial lung disease in Latin-America","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2018.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}